Cite

HARVARD Citation

    Al-Chalabi, A. et al. (2017). July 2017 ENCALS statement on edaravone. Amyotrophic lateral sclerosis and frontotemporal degeneration. 18 (7), pp. 471-474. [Online]. 
  
Back to record